Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GNE-781 is an inhibitor of CREB-binding protein (CBP) and histone acetyltransferase p300 (IC50s = 0.94 and 1.2 nM, respectively).1 It is selective for CBP and p300 over bromodomain-containing protein 4 (BRD4) bromodomain 1, BRD4 bromodomain 2, and bromodomain and PHD finger-containing 1 (BRPF1; IC50s = 5.1, 12, and 4.6 µM, respectively), as well as nine other bromodomain-containing proteins (IC50s = >18 µM for all). GNE-781 inhibits the expression of Myc in MV4-11 leukemia cells (EC50 = 6.6 nM). It reduces the differentiation of isolated human naïve CD4+ T cells into FOXP3+ inducible regulatory T cells (Tregs) in a concentration-dependent manner without affecting cell viability. Oral administration of GNE-781 (3-30 mg/kg) decreases tumor volume in a MOLM-16 acute myeloid leukemia (AML) mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. GNE-